Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | GGH | Q92820 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.46 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.46 |
| ▸ | TET3 | O43151 | 1/20 | 0.46 |
| ▸ | GABRP | O00591 | 2/20 | 0.45 |
| ▸ | GABRD | O14764 | 2/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL911001 | 0.85 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL910369 | 0.85 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL909914 | 0.85 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL2447755 | 0.84 | FOLH1 (0.67) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL19918349 | 0.84 | FOLH1 (0.52) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL1221387 | 0.84 | KMT2A (0.45) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL3334377 | 0.84 | KMT2A (0.45) | FOLH1NAALAD2RIMKLAGGH | |
| D-Glutamate SCHEMBL8219044 | 0.84 | ALOX15 (0.56) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL4998037 | 0.83 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL27341928 | 0.82 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106132456-B | Apparatus, solution and method for sample collection | 阿波根有限公司 | 2019-12-24 | — | — | CN | disclosed |
| EP-1392755-B1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | ASTELLAS PHARMA EUROP B V (NL) | 2008-12-03 | — | — | EP | disclosed |
| CN-1308375-C | Lipid-polymer-conjugates compsns. | YAMANOUCHI EUROP BV (NL) | 2007-04-04 | — | — | CN | disclosed |
| US-20040241222-A1 | Lipid-polymer-conjugates compositions | ASTELLAS PHARMA EUROPE B.V. (NL) | 2004-12-02 | — | — | US | disclosed |
| CN-1520435-A | Lipid-polymer-conjugates compsns. | ֮��ŷ������˾ | 2004-08-11 | — | — | CN | disclosed |
| EP-1392755-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002098952-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| US-4467107-A | INTERMEDIATES FOR THIENAMYCIN | MERCK & CO., INC. (US) | 1984-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040241222-A1 | Lipid-polymer-conjugates compositions | PHOSPHO1, PARG, GLUL | FOLH1 108/4885NAALAD2 312/4885RIMKLA 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.